Haleon PLC Sponsored ADR $HLN Position Increased by QRG Capital Management Inc.

QRG Capital Management Inc. grew its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 17.4% during the first quarter, Holdings Channel reports. The firm owned 379,517 shares of the company’s stock after acquiring an additional 56,362 shares during the quarter. QRG Capital Management Inc.’s holdings in Haleon were worth $3,799,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the business. Parkside Financial Bank & Trust boosted its holdings in shares of Haleon by 101.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock valued at $29,000 after buying an additional 1,433 shares during the period. Stance Capital LLC bought a new stake in shares of Haleon during the 3rd quarter valued at about $34,000. Geneos Wealth Management Inc. raised its stake in Haleon by 33.0% during the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock worth $50,000 after acquiring an additional 1,203 shares during the period. Caitong International Asset Management Co. Ltd raised its stake in Haleon by 428.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock worth $57,000 after acquiring an additional 5,124 shares during the period. Finally, Assetmark Inc. lifted its holdings in Haleon by 26.6% in the fourth quarter. Assetmark Inc. now owns 5,962 shares of the company’s stock worth $60,000 after acquiring an additional 1,252 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HLN has been the subject of a number of research reports. Rothschild & Co Redburn downgraded Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research report on Tuesday, June 30th. Wall Street Zen downgraded Haleon from a “buy” rating to a “hold” rating in a report on Saturday. Argus raised Haleon to a “strong-buy” rating in a report on Tuesday, March 17th. Finally, Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a research report on Thursday, April 30th. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Haleon currently has a consensus rating of “Moderate Buy”.

Haleon Stock Down 0.2%

HLN stock opened at $9.80 on Monday. The company has a quick ratio of 0.71, a current ratio of 0.92 and a debt-to-equity ratio of 0.47. Haleon PLC Sponsored ADR has a fifty-two week low of $8.65 and a fifty-two week high of $11.28. The firm’s 50-day simple moving average is $9.17 and its 200 day simple moving average is $9.87. The stock has a market cap of $43.22 billion, a PE ratio of 25.14, a price-to-earnings-growth ratio of 2.29 and a beta of 0.13.

Haleon (NYSE:HLN) last issued its quarterly earnings data on Saturday, February 14th. The company reported $6.32 earnings per share for the quarter. The firm had revenue of $3.65 billion during the quarter. As a group, sell-side analysts predict that Haleon PLC Sponsored ADR will post 0.55 EPS for the current year.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.